Human Tissue Authority

HTA compliance depends on traceable practice, not policy alone.

We help organisations translate consent, governance, traceability and quality requirements into working controls that can be understood, followed and evidenced.

The regulator of consent, custody and what happens next.

The Human Tissue Authority is the independent regulator for organisations that remove, store and use human tissue. It licenses and inspects activity across post-mortem examination, anatomy, research, public display, organ donation and transplantation, and tissue intended for use in patients.

Consent sits at the centre of the legislation it enforces. The HTA’s interest is whether the authority to hold and use material genuinely exists, whether the material can be accounted for, and whether daily practice still matches what was agreed, long after the person who agreed it has left the room.

Because the licensable trigger is the activity rather than the setting, organisations that would never describe themselves as tissue establishments can find themselves inside the regime.

When the evidence chain matters as much as the written rule.

HTA-regulated activity requires consistency between consent, people, premises, records, storage, transport and oversight. Small breaks in that chain can create significant uncertainty.

We help teams see the whole pathway, close operational gaps and create a proportionate assurance picture for leaders and regulators.

Focused work around the controls that must hold together.

We tailor the review to the activity and licence context, concentrating effort on the evidence, practice and accountability most likely to affect confidence.

01 / Licensing

Application and variation readiness

Clarify the route, supporting evidence, roles and dependencies before submission or operational change.

02 / Consent

Consent pathways

Test whether information, decisions, records and staff practice align across the full process.

03 / Control

Traceability and records

Review how material, decisions and documentation remain connected from receipt to final disposition.

04 / Readiness

Inspection preparation

Prioritise gaps, organise evidence and prepare responsible leaders to explain how controls operate in practice.

05 / Quality

Governance and SOP review

Strengthen ownership, review cycles, incident learning, audit and escalation around regulated activity.

06 / Response

Corrective action

Convert findings into owned, testable improvements with a clear evidence trail.

Follow the pathway from written control to daily practice.

Step 01

Map the regulated pathway

We establish the activities, interfaces, responsible roles and points where evidence can break down.

Step 02

Test records against practice

We review whether documents, staff understanding and operational controls tell the same story.

Step 03

Prioritise and assure

You receive a proportionate plan with ownership, evidence requirements and senior oversight.

Need to understand how HTA requirements interact with wider clinical governance?

Start with the service and the concern. We’ll help define the right scope.

Start a Confidential Discussion